Open6.43

High6.79

Low4.85

Volume5.18M

Average Volume2.60M

P/E-

Forward P/E-1.80

Market cap15.16M

52W H42.00

52W L2.12

Beta1.49

Dividend yield-

Open

High

Low

Volume

Average Volume

P/E

Forward P/E

Market cap

52W H

52W L

Beta

Dividend yield

IceCure Medical Ltd.

IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers the ProSense system, a single probe cryoablation system for the treatment of malignant breast tumors, as well as its associated disposables, including CryoProbes needles, and guiding needles/introducers; and IceSense3 system for ablation indications in urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MSense, a multi probe system for the treatment of multiple and larger tumors. The company serves hospitals, interventional radiological centers, ambulatory centers, and private clinics. IceCure Medical Ltd was incorporated in 2006 and is headquartered in Caesarea, Israel.

Websitehttps://www.icecure-medical.com

SectorHealthcare

IndustryMedical Devices

Number of employees

67

Short term outlookBearish

Long term outlookBearish

Website

Sector

Industry

Number of employees

Short term outlook

Long term outlook

News:

IceCure Medical Shares Jump After Update on Commercial Adoption of Breast Cancer Cryoablation Procedures
MT Newswires
•
3 days and 1 hour ago
MLTX Stock Moves Higher As Traders Position For Late-Stage Trial Catalysts
Stocktwits
•
3 days and 2 hours ago
IceCure Announces Pricing of $5.5 Million Private Placement Priced At a Premium to the Market Price with a Single Healthcare Focused Institutional Investor
PR Newswire
•
3 days and 2 hours ago
ICCM Stock On Track For Best Day In Nearly 5 Years — What’s Driving The 200% Rally?
Stocktwits
•
3 days and 3 hours ago
IceCure Reports 70% Growth in Active U.S. Commercial Install Base for Breast Cancer Cryoablation Following FDA Clearance
PR Newswire
•
3 days and 7 hours ago

ICCM

Close price of for each day

Include open price

Open6.43

High6.79

Low4.85

Volume5.18M

Average Volume2.60M

P/E-

Forward P/E-1.80

Market cap15.16M

52W H42.00

52W L2.12

Beta1.49

Dividend yield-

IceCure Medical Shares Jump After Update on Commercial Adoption of Breast Cancer Cryoablation Procedures
MT Newswires
•
3 days and 1 hour ago
MLTX Stock Moves Higher As Traders Position For Late-Stage Trial Catalysts
Stocktwits
•
3 days and 2 hours ago
IceCure Announces Pricing of $5.5 Million Private Placement Priced At a Premium to the Market Price with a Single Healthcare Focused Institutional Investor
PR Newswire
•
3 days and 2 hours ago
ICCM Stock On Track For Best Day In Nearly 5 Years — What’s Driving The 200% Rally?
Stocktwits
•
3 days and 3 hours ago
IceCure Reports 70% Growth in Active U.S. Commercial Install Base for Breast Cancer Cryoablation Following FDA Clearance
PR Newswire
•
3 days and 7 hours ago

IceCure Medical Ltd.

IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers the ProSense system, a single probe cryoablation system for the treatment of malignant breast tumors, as well as its associated disposables, including CryoProbes needles, and guiding needles/introducers; and IceSense3 system for ablation indications in urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MSense, a multi probe system for the treatment of multiple and larger tumors. The company serves hospitals, interventional radiological centers, ambulatory centers, and private clinics. IceCure Medical Ltd was incorporated in 2006 and is headquartered in Caesarea, Israel.

Websitehttps://www.icecure-medical.com

SectorHealthcare

IndustryMedical Devices

Number of employees

67

Short term outlookBearish

Long term outlookBearish

Stock.io

IceCure Medical Ltd.

IceCure Medical Ltd.